Presentation is loading. Please wait.

Presentation is loading. Please wait.

Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?  Elias Jabbour, MD, Jorge E. Cortes,

Published byMiroslav Kučera Modified over 5 years ago

Similar presentations

Presentation on theme: "Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?  Elias Jabbour, MD, Jorge E. Cortes,"— Presentation transcript:

1 Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?  Elias Jabbour, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD  Mayo Clinic Proceedings  Volume 84, Issue 2, Pages (February 2009) DOI: / Copyright © 2009 Mayo Foundation for Medical Education and Research Terms and Conditions

2 FIGURE Duration of major cytogenetic response in the randomized phase 2 trial of dasatinib vs high-dose imatinib in patients with chronic-phase chronic myeloid leukemia after failure of standard-dose imatinib therapy. From Blood.49 Mayo Clinic Proceedings  , DOI: ( / ) Copyright © 2009 Mayo Foundation for Medical Education and Research Terms and Conditions

Download ppt "Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?  Elias Jabbour, MD, Jorge E. Cortes,"

Similar presentations

Malignant Hypertension as a Presenting Symptom of Takayasu Arteritis Talya Wolak, MD, Gabriel Szendro, MD, Luis Golcman, MD, Esther Paran, MD Mayo Clinic.

Malignant Hypertension as a Presenting Symptom of Takayasu Arteritis Talya Wolak, MD, Gabriel Szendro, MD, Luis Golcman, MD, Esther Paran, MD Mayo Clinic.
Clinical Pharmacology, Uses, and Adverse Reactions of Iodinated Contrast Agents: A Primer for the Non-radiologist Jeffrey J. Pasternak, MD, Eric E. Williamson,

Clinical Pharmacology, Uses, and Adverse Reactions of Iodinated Contrast Agents: A Primer for the Non-radiologist Jeffrey J. Pasternak, MD, Eric E. Williamson,
My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages 67-76 (January 2012) DOI:

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:
Managing Cancer Pain: Basic Principles and Invasive Treatments

Managing Cancer Pain: Basic Principles and Invasive Treatments
Ductal Carcinoma in Situ of the Breast

Ductal Carcinoma in Situ of the Breast
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management  Jorge E. Cortes, Carlos.

Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management  Jorge E. Cortes, Carlos.
Cidofovir Treatment of Progressive Multifocal Leukoencephalopathy in a Patient Receiving Highly Active Antiretroviral Therapy  Raymund R. Razonable, MD,

Cidofovir Treatment of Progressive Multifocal Leukoencephalopathy in a Patient Receiving Highly Active Antiretroviral Therapy  Raymund R. Razonable, MD,
J. Eric Ahlskog, PhD, MD  Mayo Clinic Proceedings 

J. Eric Ahlskog, PhD, MD  Mayo Clinic Proceedings 
Family-Based Therapy for Adolescents With Anorexia Nervosa

Family-Based Therapy for Adolescents With Anorexia Nervosa
Evaluation of Proteinuria

Evaluation of Proteinuria
Jean L. Chan, MD, Martin J. Abrahamson, MD  Mayo Clinic Proceedings 

Jean L. Chan, MD, Martin J. Abrahamson, MD  Mayo Clinic Proceedings 
Diagnostic Options for Assessment of Postmenopausal Bleeding

Diagnostic Options for Assessment of Postmenopausal Bleeding
Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy: Case Discussion and Review of the Literature  Paul Y. Kwo, M.D., William J. Tremaine, M.D.  Mayo.

Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy: Case Discussion and Review of the Literature  Paul Y. Kwo, M.D., William J. Tremaine, M.D.  Mayo.
Treatment of Nightmares With Prazosin: A Systematic Review

Treatment of Nightmares With Prazosin: A Systematic Review
William L. Lanier, MD  Mayo Clinic Proceedings 

William L. Lanier, MD  Mayo Clinic Proceedings 
Diagnosis and Management of Chronic Kidney Disease

Diagnosis and Management of Chronic Kidney Disease
Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib by Jorge.

Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib by Jorge.
Mucinous Neoplasm of the Appendix and Pseudomyxoma Peritonei

Mucinous Neoplasm of the Appendix and Pseudomyxoma Peritonei
A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs  Charles E. Argoff,

A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs  Charles E. Argoff,
Treatment of Alcohol Withdrawal in Hospitalized Patients

Treatment of Alcohol Withdrawal in Hospitalized Patients

Similar presentations

Ads by Google